MO25-2 Clinical Outcomes of Systemic Therapy for Metastatic Renal Cell Carcinoma Patients on Hemodialysis
ANNALS OF ONCOLOGY(2023)
摘要
The prognosis of patients with metastatic renal cell carcinoma (mRCC) has been markedly improved with the introduction of molecular targeted agents and immune checkpoint inhibitors. However, there are few reports on the outcomes of systemic therapy for mRCC patients on hemodialysis. The purpose of this study was to evaluate the clinical outcomes of systemic therapy for mRCC patients on hemodialysis.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要